23 results
Thumbnail

D1.02 - Prevalence of allergic respiratory disorders in urban V/s rural Indian population

Thumbnail

D1.03 - Sustainable and gluten free bread: Are legumes a hidden risk for occupational IgE-mediated respiratory allergy?

Thumbnail

D1.04 - Diagnostic approach for respiratory symptoms linked to microbial contamination in metalworking fluids

Thumbnail

D1.05 - Bet v 6 as a Marker of Pollen Cross-Reactivity in Southern Europe: Insights from a Birch-Free Region

Thumbnail

D1.07 - Profile of sensitization to inhalant allergens in Valencia: Analysis of 1.898 skin prick tests over one year

Thumbnail

D1.09 - Dynamics of pollen allergy in Ukraine during the full-scale invasion shows demand for diagnostics increased with changed sensitization patterns seen

Thumbnail

D1.10 - Tree pollen allergy profile in Ukraine assessed by large-scale molecular component analysis

Thumbnail

D1.11 - Age and Gender Patterns in Fungal Allergen Sensitization: A Study from Central Ukraine

Thumbnail

D1.13 - EHealth tools suitability and technologic innovation use in an Environmental Exposure Chamber

Thumbnail

D1.14 - Molecular Allergy Profiling of Pollen Sensitization in Cluj-Napoca

Thumbnail

D1.15 - Relationship between sensitization to peanuts and tree nuts in children with allergic diseases in a population of the Russian Federation

Thumbnail

D1.12 - Optimal Conventional Diagnostic Approach for Wheat Allergy in Chinese Children

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series

Thumbnail

D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"